NABRIVA THERAPEUTICS PLC (NBRV)

IE000OZRGNV6 - Common Stock

1.42  0 (0%)

After market: 1.3986 -0.02 (-1.51%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-3-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
36.51M36.94M28.89M5.03M9.48M
Cost Of Goods
29.66M28.58M13.15M770.00K70.00K
Gross Profit
6.85M8.35M15.75M4.26M9.41M
Operating Expenses
54.94M59.53M64.28M70.38M88.90M
Research and Development
13.37M14.26M12.63M15.10M26.42M
Selling, General, and Administrative Expenses
41.57M45.26M51.65M55.29M62.49M
Operating Income
-48.09M-51.17M-48.53M-66.12M-79.49M
Interest Income/Expense
-677.00K-698.00K-901.00K-1.65M-3.39M
Other Income/Expense
232.00K571.00K469.00K1.19M220.00K
Non Recurring Items
N/A-4.32M0.00-2.76MN/A
Income Before Taxes
-52.85M-55.62M-48.96M-69.35M-82.66M
Income Tax
1.21M1.57M490.00K140.00K100.00K
Net Income
-54.07M-57.19M-49.45M-69.48M-82.76M
EBITDA
-47.93M-50.96M-48.17M-65.70M-79.09M
 
Per Share Data
EPS Diluted Total Ops
-18.63-21.32-28.52-5.41-11.15
Non GAAP EPS
N/AN/A-27.02-147.75-280.00
 
Statistics
Gross Profit Margin
18.76%22.62%54.50%84.69%99.26%
Profit Margin
-148.11%-154.83%-171.14%-1381.31%-873.00%
Operating Profit Margin
-131.74%-138.55%-167.95%-1314.51%-838.50%

All data in USD

Charts